Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN106995413A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106995413A reveals high-ee iridium-catalyzed hydrogenation for chiral piperazines, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.